These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16047109)

  • 21. Visual symptoms in the presentation of Creutzfeldt-Jakob disease.
    Wong A; Matheos K; Danesh-Meyer HV
    J Clin Neurosci; 2015 Oct; 22(10):1688-9. PubMed ID: 26355534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dark side of the (half) moon.
    Pellegrini F; Stafa A; Bonsanto D; Fraser CL
    Surv Ophthalmol; 2020; 65(3):381-385. PubMed ID: 30772362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Heidenhain variant of Creutzfeldt-Jakob disease.
    Hunt A; Ibrahim K; Rahmani MJ
    Br J Hosp Med (Lond); 2018 Dec; 79(12):712-713. PubMed ID: 30526111
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.
    Kim EJ; Cho SS; Jeong BH; Kim YS; Seo SW; Na DL; Geschwind MD; Jeong Y
    Eur J Neurol; 2012 Mar; 19(3):488-93. PubMed ID: 22050286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creutzfeldt-Jakob disease manifesting as posterior cortical dementia.
    Nodera H; Mori A; Izumi Y; Sakamoto T; Kaji R
    Neurology; 2005 Jul; 65(2):330. PubMed ID: 16043815
    [No Abstract]   [Full Text] [Related]  

  • 26. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teaching NeuroImages: DWI and EEG findings in Creutzfeldt-Jakob disease.
    Ganesh A; Hoyte LC; Agha-Khani Y; Yeung MMC
    Neurology; 2018 Apr; 90(16):e1450-e1451. PubMed ID: 29661908
    [No Abstract]   [Full Text] [Related]  

  • 28. The MM2-cortical form of sporadic Creutzfeldt-Jakob disease presenting with visual disturbance.
    Nozaki I; Hamaguchi T; Noguchi-Shinohara M; Ono K; Shirasaki H; Komai K; Kitamoto T; Yamada M
    Neurology; 2006 Aug; 67(3):531-3. PubMed ID: 16894125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease.
    Renard D; Collombier L; Castelnovo G; Remy A; Laplanche JL; Labauge P
    Arch Neurol; 2008 Oct; 65(10):1390-1. PubMed ID: 18852360
    [No Abstract]   [Full Text] [Related]  

  • 30. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.
    Friedland RP; Prusiner SB; Jagust WJ; Budinger TF; Davis RL
    J Comput Assist Tomogr; 1984 Oct; 8(5):978-81. PubMed ID: 6381559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spreading dystonia in probable Creutzfeldt-Jakob disease with serial diffusion-weighted magnetic resonance images.
    Lee SH; Suh SI; Koh SB
    Eur Neurol; 2007; 58(2):122-4. PubMed ID: 17570921
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnostic challenge of non-specific visual symptoms: consideration of Heidenhain variant of Creutzfeldt-Jakob disease.
    Ntantos D; Aggelopoulos P; Kazis D; Dagklis IE; Bostantjopoulou S
    Clin Exp Optom; 2018 Mar; 101(2):311-313. PubMed ID: 28921636
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings.
    Zhang Y; Minoshima S; Vesselle H; Lewis DH
    Clin Nucl Med; 2012 Jul; 37(7):e173-5. PubMed ID: 22691528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of diffusion-weighted magnetic resonance imaging with neurological deficits in sporadic Creutzfeldt-Jakob Disease].
    Eschweiler GW; Wormstall H; Widmann U; Naegele T; Bartels M
    Nervenarzt; 2002 Sep; 73(9):883-6. PubMed ID: 12215882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities.
    Abbadessa G; Lavorgna L; Miele G; Cirillo M; Bonavita S
    Acta Neurol Belg; 2020 Aug; 120(4):1007-1009. PubMed ID: 32436078
    [No Abstract]   [Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease presenting with visual blurring, diplopia and visual loss: Heidenhain's variant.
    Lee KE; Loh NK; Tan AK; Lee WL; Tjia HT
    Ann Acad Med Singap; 1998 Nov; 27(6):854-6. PubMed ID: 10101563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Type Heidenhain of the subacute spongious encephalopathy (SSE) Creutzfeldt-Jakob (author's transl)].
    Hopf HC; Althaus HH; Sabuncu S
    Z Neurol; 1974 Feb; 206(2):149-56. PubMed ID: 4133864
    [No Abstract]   [Full Text] [Related]  

  • 38. Creutzfeldt-Jakob Disease Mimicking Alzheimer Disease and Dementia With Lewy Bodies-Findings of FDG PET With 3-Dimensional Stereotactic Surface Projection.
    Miyazawa N
    Clin Nucl Med; 2017 May; 42(5):e247-e248. PubMed ID: 28240664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease.
    Nagasaka T; Nagasaka K; Ohta E; Shindo K; Takiyama Y; Shiozawa Z; Miyazawa N; Yamasaki N; Mori N; Onda H; Shinohara T
    Clin Nucl Med; 2011 Aug; 36(8):725-7. PubMed ID: 21716034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography in diagnosis of visual variant Alzheimer disease.
    Finelli PF
    J Neuroophthalmol; 2009 Jun; 29(2):149-50. PubMed ID: 19491642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.